Madrigal Pharmaceuticals Statistics

Total Valuation

MDGL has a market cap or net worth of $6.70 billion. The enterprise value is $5.79 billion.

Market Cap	6.70B
Enterprise Value	5.79B

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025, before market open.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

MDGL has 21.81 million shares outstanding. The number of shares has increased by 14.83% in one year.

Current Share Class	21.81M
Shares Outstanding	21.81M
Shares Change (YoY)	+14.83%
Shares Change (QoQ)	+1.60%
Owned by Insiders (%)	8.27%
Owned by Institutions (%)	67.97%
Float	11.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	79.26
Forward PS	14.33
PB Ratio	8.24
P/TBV Ratio	8.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	75.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.98, with a Debt / Equity ratio of 0.15.

Current Ratio	5.98
Quick Ratio	5.79
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-36.19

Financial Efficiency

Return on equity (ROE) is -129.76% and return on invested capital (ROIC) is -66.18%.

Return on Equity (ROE)	-129.76%
Return on Assets (ROA)	-52.25%
Return on Capital (ROIC)	-66.18%
Revenue Per Employee	$204,290
Profits Per Employee	-$1.38M
Employee Count	376
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.59% in the last 52 weeks. The beta is -0.37, so MDGL's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	+35.59%
50-Day Moving Average	315.53
200-Day Moving Average	261.50
Relative Strength Index (RSI)	50.82
Average Volume (20 Days)	415,325

Short Selling Information

The latest short interest is 4.11 million, so 18.83% of the outstanding shares have been sold short.

Short Interest	4.11M
Short Previous Month	4.73M
Short % of Shares Out	18.83%
Short % of Float	36.90%
Short Ratio (days to cover)	13.08

Income Statement

In the last 12 months, MDGL had revenue of $76.81 million and -$518.67 million in losses. Loss per share was -$25.02.

Revenue	76.81M
Gross Profit	74.03M
Operating Income	-548.06M
Pretax Income	-510.45M
Net Income	-518.67M
EBITDA	-547.18M
EBIT	-548.06M
Loss Per Share	-$25.02

Full Income Statement

Balance Sheet

The company has $998.63 million in cash and $119.14 million in debt, giving a net cash position of $879.49 million or $40.32 per share.

Cash & Cash Equivalents	998.63M
Total Debt	119.14M
Net Cash	879.49M
Net Cash Per Share	$40.32
Equity (Book Value)	777.16M
Book Value Per Share	35.64
Working Capital	885.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$431.02 million and capital expenditures -$2.30 million, giving a free cash flow of -$433.32 million.

Operating Cash Flow	-431.02M
Capital Expenditures	-2.30M
Free Cash Flow	-433.32M
FCF Per Share	-$19.87

Full Cash Flow Statement

Margins

Gross Margin	96.37%
Operating Margin	-713.49%
Pretax Margin	-675.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MDGL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.83%
Shareholder Yield	-14.83%
Earnings Yield	-7.77%
FCF Yield	-6.49%

Dividend Details

Analyst Forecast

The average price target for MDGL is $351.67, which is 14.52% higher than the current price. The consensus rating is "Buy".

Price Target	$351.67
Price Target Difference	14.52%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MDGL has an Altman Z-Score of 6.58 and a Piotroski F-Score of 2.

Altman Z-Score	6.58
Piotroski F-Score	2